File(s) under permanent embargo
A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling
journal contributionposted on 2023-06-29, 05:59 authored by Martina Lichtenfels, Noely Paula Cristina Lorenzi, Maricy Tacla, Kaori YokochiKaori Yokochi, Flávia Frustockl, Camila Alves Silva, André Luiz da Silva, Lara Termini, Caroline Brunetto Farias
Abstract Objective To evaluate the accuracy and patient acceptability toward self-sampling using a new device - SelfCervix® - for detecting HPV-DNA. Methods A total of 73 women aged 25–65 who underwent regular cervical cancer screening from March to October 2016 were included. Women performed self-sampling followed by a physician-sampling, and the samples were analyzed for HPV-DNA. After that, patients were surveyed about their acceptability of self-sampling. Results HPV-DNA detection rate of self-sampling presented high accuracy and was similar to physician-collection. Sixty-four (87.7%) patients answered the acceptability survey. Most patients (89%) considered the self-sampling comfortable, and 82.5% preferred self-sampling to physician-sampling. The reasons cited were time-saving and convenience. Fifty-one (79.7%) reported that they would recommend self-sampling. Conclusion Self-sampling using the new Brazilian device SelfCervix® is not inferior in HPV-DNA detection rate compared with physician-collection, and patients are supportive of the method. Therefore, it might be an option to reach under-screened populations in Brazil.